Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis.

Grant JL, Ghosn EE, Axtell RC, Herges K, Kuipers HF, Woodling NS, Andreasson K, Herzenberg LA, Herzenberg LA, Steinman L.

Sci Transl Med. 2012 Aug 1;4(145):145ra105. doi: 10.1126/scitranslmed.3004145.

2.

Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.

Herges K, de Jong BA, Kolkowitz I, Dunn C, Mandelbaum G, Ko RM, Maini A, Han MH, Killestein J, Polman C, Goodyear AL, Dunn J, Steinman L, Axtell RC.

Mult Scler. 2012 Apr;18(4):398-408. doi: 10.1177/1352458512440060. Epub 2012 Feb 16.

3.

Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.

Herges K, Millward JM, Hentschel N, Infante-Duarte C, Aktas O, Zipp F.

PLoS One. 2011;6(10):e25456. doi: 10.1371/journal.pone.0025456. Epub 2011 Oct 13.

4.

Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients.

Bock M, Brandt AU, Dörr J, Kraft H, Weinges-Evers N, Gaede G, Pfueller CF, Herges K, Radbruch H, Ohlraun S, Bellmann-Strobl J, Kuchenbecker J, Zipp F, Paul F.

Clin Neurol Neurosurg. 2010 Oct;112(8):647-52. doi: 10.1016/j.clineuro.2010.04.014. Epub 2010 May 10.

PMID:
20452719
5.

Attention Network Test reveals alerting network dysfunction in multiple sclerosis.

Urbanek C, Weinges-Evers N, Bellmann-Strobl J, Bock M, Dörr J, Hahn E, Neuhaus AH, Opgen-Rhein C, Ta TM, Herges K, Pfueller CF, Radbruch H, Wernecke KD, Ohlraun S, Zipp F, Dettling M, Paul F.

Mult Scler. 2010 Jan;16(1):93-9. doi: 10.1177/1352458509350308. Epub 2009 Dec 7.

PMID:
19995842

Supplemental Content

Loading ...
Support Center